Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
Danuta M Skowronski, Samantha E Kaweski, Michael A Irvine, Shinhye Kim, Erica SY Chuang, Suzana Sabaiduc, Mieke Fraser, Romina C Reyes, Bonnie Henry, Paul N Levett, Martin Petric, Mel Krajden, Inna Sekirov
doi: https://doi.org/10.1101/2022.09.09.22279751
Danuta M Skowronski
1BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada
2University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada
MD, FRCPCSamantha E Kaweski
3BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada
MScMichael A Irvine
4BC Centre for Disease Control, Data and Analytic Services
5Simon Fraser University, Faculty of Health Sciences, Burnaby, British Columbia, Canada
PhDShinhye Kim
1BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada
MScErica SY Chuang
1BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada
MPHSuzana Sabaiduc
2University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada
BScMieke Fraser
4BC Centre for Disease Control, Data and Analytic Services
GISPRomina C Reyes
6University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada
7LifeLabs, Burnaby, British Columbia, Canada
MSc, MD, FRCPCBonnie Henry
2University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada
8Office of the Provincial Health Officer, Ministry of Health, Victoria, British Columbia, Canada
MD, FRCPCPaul N Levett
3BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada
6University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada
PhD, DScMartin Petric
6University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada
PhDMel Krajden
3BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada
6University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada
MD, FRCPCInna Sekirov
3BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada
6University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada
MD, PhD, FRCPC![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Aggregate data are available within the manuscript and the supplementary material. Any further data sharing will be considered upon reasonable request to the corresponding author with appropriate review and aggregation as required to comply with the provincial legislation under which the data were assembled and respecting privacy and confidentiality requirements.
Posted September 09, 2022.
Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
Danuta M Skowronski, Samantha E Kaweski, Michael A Irvine, Shinhye Kim, Erica SY Chuang, Suzana Sabaiduc, Mieke Fraser, Romina C Reyes, Bonnie Henry, Paul N Levett, Martin Petric, Mel Krajden, Inna Sekirov
medRxiv 2022.09.09.22279751; doi: https://doi.org/10.1101/2022.09.09.22279751
Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
Danuta M Skowronski, Samantha E Kaweski, Michael A Irvine, Shinhye Kim, Erica SY Chuang, Suzana Sabaiduc, Mieke Fraser, Romina C Reyes, Bonnie Henry, Paul N Levett, Martin Petric, Mel Krajden, Inna Sekirov
medRxiv 2022.09.09.22279751; doi: https://doi.org/10.1101/2022.09.09.22279751
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)